New CVS Health Report Highlights the Company's Role as a Top U.S. Employer, Investing in Improving Health and Supporting Local Communities

April 20, 2026 9:00 AM

CVS Health® (NYSE:CVS) recently released its inaugural National Economic Impact Report demonstrating the positive economic impact that the company has in communities across the country.The report demonstrates how CVS Health delivers $474 billion annually for the U.S. economy and supports 1.3 million jobs nationwide through its operations in every U.S. state and Washington, D.C. In addition, CVS Health operations generated $58.6 billion in local,...

Read more

Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition

April 20, 2026 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company") today announced that it has closed the second and final tranche of the private placement announced on February 11, 2026 (the "Offering") for the purchase and sale of 26,250 shares of Series A Convertible Preferred Stock.Pursuant to the closing of the second and final tranche of the Offering, the Company issued an aggregate of 12,500 Preferred Shares for gross proceeds of...

Read more

See, What Had Happened Was...

April 20, 2026 5:00 AM

Bionic Bloom founded by Angela Fisher, is announcing its newest immersive experience: a shadow work retreat-a psychologically rich, deeply interactive weekend designed to explore the parts of ourselves we often avoid, deflect, or unknowingly project onto others.The title is intentional. It mirrors the familiar narrative people use to explain behavior after the fact-often softening, reframing, or distancing from uncomfortable truths. This retreat...

Read more

Case Management Services to Close Gaps in Patient Care

April 20, 2026 5:00 AM

Bionic Bloom Wellness Collective and the Neurodivergent Empowerment Institute (NEI), founded by Angela Fisher, today announced the launch of a comprehensive Case Management program designed to bridge the gaps between medical, mental health, and supportive services.The new program establishes a continuous layer of care coordination for patients navigating complex needs, ensuring that treatment plans are not only created-but followed through with...

Read more

Last Patient has Completed AlzeCure's Phase Ib Clinical Study with NeuroRestore ACD856

April 20, 2026 4:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, today announced that the last patient's last visit (LPLV) has now occurred in the ongoing Phase Ib clinical trial of ACD856, the lead drug candidate within the NeuroRestore platform, which is being developed for Alzheimer's disease and other indications."Previous...

Read more

Senzime Wins Expanded Contract Within Leading Southeastern US Hospital System

April 20, 2026 3:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB today announced that it has expanded its agreements with a leading hospital system (IDN) with network in the southeastern US. With today's expansion contract for additional 65 TetraGraph-systems, the network will have over 160 TetraGraph's installed, generating an estimated annual recurring revenue exceeding SEK 6 million for Senzime."Another great US contract and a strong showcase of our ability to...

Read more

Genflow Biosciences PLC Announces Strategic Technology Collaboration

April 20, 2026 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European biotechnology company focused on the development of gene therapies for age-related diseases, today announces that it has entered into a strategic technology collaboration with Acuitas Therapeutics ("Acuitas"), a globally recognised leader in lipid nanoparticle ("LNP") delivery systems whose technology has underpinned some of the most commercially successful...

Read more

Who Does the Best Deep Plane Facelift in Florida?

April 20, 2026 12:00 AM

Interest in advanced facial rejuvenation continues to grow as patients are actively looking for natural-looking & long-lasting results. Among available techniques, the deep plane facelift is widely recognized for addressing deeper facial structures rather than tightening skin alone. In Florida, where cosmetic surgery is highly competitive, surgeon expertise plays a decisive role. Based on clinical experience, surgical volume, and technique...

Read more

4/20 and the Future of Cannabis Medicine: Why Botanical Therapies Must Meet Real Scientific Standards

April 19, 2026 11:15 PM

As the nation marks 4/20, a day long associated with cannabis culture and advocacy, MMJ International Holdings is calling attention to a critical distinction often overlooked in the celebration: There is a difference between cannabis access and cannabis medicine.While public momentum continues to reshape federal cannabis policy, one principle must remain clear:Botanical therapies must meet reproducibility, safety, and clinical-trial standards...

Read more

Dr. Hope Jacoby Calls for Earlier Intervention in Foot and Wound Care

April 19, 2026 10:50 PM

The Cost of Delayed CareFoot and ankle conditions rarely announce themselves dramatically. A wound that does not heal. A structural problem that causes a gradual shift in gait. Chronic pain that gets absorbed into daily routine until it cannot be anymore.By the time many patients seek specialized care, the condition has progressed further than it needed to. Dr. Hope Jacoby, a Doctor of Podiatric Medicine and owner of Texas Wound Pros and Foot...

Read more

Dr. Nikesh Seth Outlines Seven Commitments to Patients at Global Pain Solutions

April 19, 2026 10:35 PM

A New Practice, A Clear StandardWhen Dr. Nikesh Seth founded Global Pain Solutions in Scottsdale, Arizona in December 2025, he made a set of concrete commitments that would define how the practice operates. Having previously built and sold Integrated Pain Consultants, one of the largest independent pain management groups in the Southwest, Seth chose to return to independent practice with a smaller model and a more explicit standard of care.The...

Read more

Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock

April 19, 2026 7:50 PM

Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced the pricing of a registered direct offering (the "Offering") consisting of 750,000 shares of the Company's common stock at an offering price of $4.50 per share. The gross proceeds to the Company from the Offering are estimated to be approximately $3.4 million before deducting placement agent fees and...

Read more

Integrated Case Management Services to Close Gaps in Patient Care

April 19, 2026 3:15 PM

Bionic Bloom Wellness Collective and the Neurodivergent Empowerment Institute (NEI), founded by Angela Fisher, today announced the launch of a comprehensive Case Management program designed to bridge the gaps between medical, mental health, and supportive services.The new program establishes a continuous layer of care coordination for patients navigating complex needs, ensuring that treatment plans are not only created-but followed through with...

Read more

Medicure Announces Resignation of President and Chief Operating Officer

April 17, 2026 7:35 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today reported that Dr. Neil Owens has resigned as President and Chief Operating Officer, effective on or before May 31, 2026.Dr. Albert D. Friesen, CEO and Chair of the Board of Directors, stated, "On behalf of our Board...

Read more

Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development

April 17, 2026 7:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H) (WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce the appointments of Dr. Islam Mohamed as Chief Medical Officer (CMO) and Stephen M. Novak as Chief of Research and Development (R&D). These strategic leadership additions are intended to strengthen the Company's clinical and development capabilities as it advances its lead product candidate, ONC010, also known as its...

Read more

Advanced Urology Expands Minimally Invasive Prostate Treatment Offerings Through Partnership with Francis Medical and Introduction of Vanquish(R) Water Vapor Ablation

April 17, 2026 4:35 PM

Advanced Urology, a leading provider of comprehensive urologic care in the Southeast, today announced the successful completion of its first procedures using the Vanquish® Water Vapor Ablation System through its partnership with Francis Medical, Inc. This minimally invasive technology is designed to ablate targeted prostate tissue and represents a significant advancement in the practice's expanding focal therapy program.The procedures were...

Read more

Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC

April 17, 2026 3:15 PM

Cantargia (STO:CANTA) - Cantargia AB (Publ) (Nasdaq Stockholm:CANTA) today reported that the rationale and study design of the phase 1b/2 clinical trial investigating nadunolimab in combination with immune-checkpoint inhibitor therapy in patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer (CRC) will be presented at the AACR annual meeting. The clinical trial is an investigator-led initiative in...

Read more

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

April 17, 2026 3:00 PM

Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data from a Phase 1/2 study of mRNA-4359, an investigational cancer antigen therapy, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA, on April 17-22, 2026. The presentation reports safety, efficacy and translational data from a Phase 2 dose-expansion cohort of the Phase 1/2 study (NCT05533697), which evaluated mRNA-4359 +...

Read more

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

April 17, 2026 2:00 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the planned Q2 2026 U.S. market launch of Cur18™, a next-generation curcumin supplement, marking a further step in the Company's expansion into the U.S. nutraceutical market.Cur18™ enters the U.S. curcumin category as a science-driven alternative to conventional curcumin formulations, addressing one...

Read more

Notice of Annual General Meeting in Senzime AB (publ)

April 17, 2026 12:00 PM

Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general meeting on Tuesday 19 May 2026 at 16.00 at the Company's premises on Verkstadsgatan 8, house 1, Uppsala.Notice etc.Shareholders who wish to participate in the annual general meeting must:be registered in the share register kept by Euroclear Sweden AB on Friday 8 May 2026 (the record date),...

Read more